Literature DB >> 23408864

Elevation of proinflammatory cytokines in patients with Aicardi-Goutières syndrome.

Asako Takanohashi1, Morgan Prust, Jichuan Wang, Heather Gordish-Dressman, Miriam Bloom, Gillian I Rice, Johanna L Schmidt, Yanick J Crow, Pierre Lebon, Taco W Kuijpers, Kanneboyina Nagaraju, Adeline Vanderver.   

Abstract

OBJECTIVE: This study explores a large panel of cytokines in plasma and CSF of patients with Aicardi-Goutières syndrome (AGS) at different ages, in order to establish signatures of cytokines most predictive of AGS.
METHODS: Plasma from 22 subjects with known mutations were assayed for cytokines using the Milliplex MAP Immunobead system, and compared to results from 8 age-matched normal controls. CSF of 11 additional patients with mutation-proven AGS was tested in an identical manner and compared to results from age-matched controls. Samples were banked and analysis was carried out retrospectively.
RESULTS: Significant elevations were seen in FMS-related tyrosine kinase 3 ligand, IP-10, interleukin (IL)-12p40, IL-15, tumor necrosis factor α, and soluble IL 2 receptor α in both AGS patient plasma and CSF relative to controls. Additionally, this cytokine signature was able to correctly cluster 9 of 11 AGS cases based on CSF values. While most cytokines decreased exponentially with age, a subgroup including IP-10 demonstrated persistent elevation beyond early childhood.
CONCLUSION: Patients with AGS exhibit plasma and CSF elevations of proinflammatory cytokines. Selected cytokines remain persistently elevated beyond the initial disease phase. This panel of proinflammatory cytokines may be considered for use as diagnostic and therapeutic markers of disease, and may permit improved understanding of disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408864      PMCID: PMC3653200          DOI: 10.1212/WNL.0b013e3182872694

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Interferon and Aicardi-Goutières syndrome.

Authors:  Pierre Lebon; Jean François Meritet; Anne Krivine; Flore Rozenberg
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

2.  A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines.

Authors:  Asgar Zaheer; Smita Zaheer; Shailendra K Sahu; Scott Knight; Houdy Khosravi; Satya N Mathur; Ramon Lim
Journal:  J Neurochem       Date:  2007-01-22       Impact factor: 5.372

3.  Case of Aicardi-Goutières syndrome with long-lasting increase of cerebrospinal interferon-alpha.

Authors:  Petia S Dimova; Olya A Mikova
Journal:  J Child Neurol       Date:  2005-11       Impact factor: 1.987

4.  Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.

Authors:  Jing Hua; Kyriakos Kirou; Christina Lee; Mary K Crow
Journal:  Arthritis Rheum       Date:  2006-06

5.  The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.

Authors:  Ewa Bien; Malgorzata Rapala; Malgorzata Krawczyk; Anna Balcerska
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553

6.  Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy.

Authors:  P Lebon; J Badoual; G Ponsot; F Goutières; F Hémeury-Cukier; J Aicardi
Journal:  J Neurol Sci       Date:  1988-04       Impact factor: 3.181

7.  Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutières syndrome.

Authors:  Jane T van Heteren; Flore Rozenberg; Eleonora Aronica; Dirk Troost; Pierre Lebon; Taco W Kuijpers
Journal:  Glia       Date:  2008-04       Impact factor: 7.452

8.  An autoimmune disease prevented by anti-retroviral drugs.

Authors:  Gabriele B Beck-Engeser; Dan Eilat; Matthias Wabl
Journal:  Retrovirology       Date:  2011-11-08       Impact factor: 4.602

9.  Clinical and molecular phenotype of Aicardi-Goutieres syndrome.

Authors:  Gillian Rice; Teresa Patrick; Rekha Parmar; Claire F Taylor; Alec Aeby; Jean Aicardi; Rafael Artuch; Simon Attard Montalto; Carlos A Bacino; Bruno Barroso; Peter Baxter; Willam S Benko; Carsten Bergmann; Enrico Bertini; Roberta Biancheri; Edward M Blair; Nenad Blau; David T Bonthron; Tracy Briggs; Louise A Brueton; Han G Brunner; Christopher J Burke; Ian M Carr; Daniel R Carvalho; Kate E Chandler; Hans-Jurgen Christen; Peter C Corry; Frances M Cowan; Helen Cox; Stefano D'Arrigo; John Dean; Corinne De Laet; Claudine De Praeter; Catherine Dery; Colin D Ferrie; Kim Flintoff; Suzanna G M Frints; Angels Garcia-Cazorla; Blanca Gener; Cyril Goizet; Francoise Goutieres; Andrew J Green; Agnes Guet; Ben C J Hamel; Bruce E Hayward; Arvid Heiberg; Raoul C Hennekam; Marie Husson; Andrew P Jackson; Rasieka Jayatunga; Yong-Hui Jiang; Sarina G Kant; Amy Kao; Mary D King; Helen M Kingston; Joerg Klepper; Marjo S van der Knaap; Andrew J Kornberg; Dieter Kotzot; Wilfried Kratzer; Didier Lacombe; Lieven Lagae; Pierre Georges Landrieu; Giovanni Lanzi; Andrea Leitch; Ming J Lim; John H Livingston; Charles M Lourenco; E G Hermione Lyall; Sally A Lynch; Michael J Lyons; Daphna Marom; John P McClure; Robert McWilliam; Serge B Melancon; Leena D Mewasingh; Marie-Laure Moutard; Ken K Nischal; John R Ostergaard; Julie Prendiville; Magnhild Rasmussen; R Curtis Rogers; Dominique Roland; Elisabeth M Rosser; Kevin Rostasy; Agathe Roubertie; Amparo Sanchis; Raphael Schiffmann; Sabine Scholl-Burgi; Sunita Seal; Stavit A Shalev; C Sierra Corcoles; Gyan P Sinha; Doriette Soler; Ronen Spiegel; John B P Stephenson; Uta Tacke; Tiong Yang Tan; Marianne Till; John L Tolmie; Pam Tomlin; Federica Vagnarelli; Enza Maria Valente; Rudy N A Van Coster; Nathalie Van der Aa; Adeline Vanderver; Johannes S H Vles; Thomas Voit; Evangeline Wassmer; Bernhard Weschke; Margo L Whiteford; Michel A A Willemsen; Andreas Zankl; Sameer M Zuberi; Simona Orcesi; Elisa Fazzi; Pierre Lebon; Yanick J Crow
Journal:  Am J Hum Genet       Date:  2007-09-04       Impact factor: 11.025

10.  Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus.

Authors:  Yanick J Crow; Bruce E Hayward; Rekha Parmar; Peter Robins; Andrea Leitch; Manir Ali; Deborah N Black; Hans van Bokhoven; Han G Brunner; Ben C Hamel; Peter C Corry; Frances M Cowan; Suzanne G Frints; Joerg Klepper; John H Livingston; Sally Ann Lynch; Roger F Massey; Jean François Meritet; Jacques L Michaud; Gerard Ponsot; Thomas Voit; Pierre Lebon; David T Bonthron; Andrew P Jackson; Deborah E Barnes; Tomas Lindahl
Journal:  Nat Genet       Date:  2006-07-16       Impact factor: 38.330

View more
  8 in total

Review 1.  Aicardi-Goutières syndrome and the type I interferonopathies.

Authors:  Yanick J Crow; Nicolas Manel
Journal:  Nat Rev Immunol       Date:  2015-06-05       Impact factor: 53.106

Review 2.  Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).

Authors:  Pui Y Lee; Ivona Aksentijevich; Qing Zhou
Journal:  Semin Immunopathol       Date:  2022-02-17       Impact factor: 9.623

3.  DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes.

Authors:  Marco Luciani; Francesca Gatto; Monah Abou Alezz; Anna Maria Sole Giordano; Chiara Beghè; Lucrezia Della Volpe; Alessandro Migliara; Sara Valsoni; Marco Genua; Monika Dzieciatkowska; Giacomo Frati; Julie Tahraoui-Bories; Silvia Clara Giliani; Simona Orcesi; Elisa Fazzi; Renato Ostuni; Angelo D'Alessandro; Raffaella Di Micco; Ivan Merelli; Angelo Lombardo; Martin A M Reijns; Natalia Gromak; Angela Gritti; Anna Kajaste-Rudnitski
Journal:  J Exp Med       Date:  2022-03-09       Impact factor: 14.307

4.  RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.

Authors:  Maria Pujantell; Eva Riveira-Muñoz; Roger Badia; Marc Castellví; Edurne Garcia-Vidal; Guillem Sirera; Teresa Puig; Cristina Ramirez; Bonaventura Clotet; José A Esté; Ester Ballana
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

5.  Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.

Authors:  Kelly D Sullivan; Donald Evans; Ahwan Pandey; Thomas H Hraha; Keith P Smith; Neil Markham; Angela L Rachubinski; Kristine Wolter-Warmerdam; Francis Hickey; Joaquin M Espinosa; Thomas Blumenthal
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

Review 6.  Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Authors:  Michael R Pranzatelli
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

7.  Functionally-interdependent shape-switching nanoparticles with controllable properties.

Authors:  Justin R Halman; Emily Satterwhite; Brandon Roark; Morgan Chandler; Mathias Viard; Anna Ivanina; Eckart Bindewald; Wojciech K Kasprzak; Martin Panigaj; My N Bui; Jacob S Lu; Johann Miller; Emil F Khisamutdinov; Bruce A Shapiro; Marina A Dobrovolskaia; Kirill A Afonin
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

8.  Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response.

Authors:  Karen J Mackenzie; Paula Carroll; Laura Lettice; Žygimantė Tarnauskaitė; Kaalak Reddy; Flora Dix; Ailsa Revuelta; Erika Abbondati; Rachel E Rigby; Björn Rabe; Fiona Kilanowski; Graeme Grimes; Adeline Fluteau; Paul S Devenney; Robert E Hill; Martin Am Reijns; Andrew P Jackson
Journal:  EMBO J       Date:  2016-02-22       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.